-
Pfizer COVID-19 Vaccine Could Get Emergency Approval By Friday, FDA Advisor Says
Monday, December 7, 2020 - 10:11pm | 406A member of a United States Food and Drug Administration committee on vaccines said that the agency could issue an emergency authorization for Pfizer Inc’s (NYSE: PFE) COVID-19 vaccine as early as Friday. What Happened: James Hildreth, a member of the Vaccines and Related Biological Products...
-
Eli Lilly's Arthritis Drug Gets Emergency Use Approval For Treatment Of COVID-19
Thursday, November 19, 2020 - 11:47pm | 537Eli Lilly And Co’s (NYSE: LLY) rheumatoid arthritis drug baricitinib has been issued an emergency use authorization, in combination with Gilead Sciences, Inc’s (NASDAQ: GILD) remdesivir, for the treatment of COVID-19 in adults and children who are hospitalized and require supplemental...
-
Pfizer Expected To File For FDA Emergency Approval on Friday, Followed Closely By Moderna, Azar Says
Thursday, November 19, 2020 - 10:49pm | 395Pfizer Inc (NYSE: PFE) is likely to file an application with the United States Food and Drug Administration for emergency use of its COVID-19 vaccine on Friday, with Moderna Inc (NASDAQ: MRNA) to do the same shortly after. What Happened: The disclosure on Pfizer’s COVID-19 vaccine was made by...
-
No Conclusive Evidence On Convalescent Plasma Use Against COVID-19, NIH Says After FDA Emergency Use Approval
Tuesday, September 1, 2020 - 11:59pm | 436The National Institutes Of Health said Tuesday that after reviewing available evidence from published and unpublished data on convalescent plasma therapy for COVID-19, it had concluded there is no case for recommending or advising against such a treatment. What Happened: The COVID-19 Treatment...
-
Roche To Launch Rapid COVID-19 Test In Europe This Month, Seek FDA Emergency Use Approval
Tuesday, September 1, 2020 - 11:01pm | 409Roche Holding AG (OTC: RHHBY) said Tuesday it will launch a COVID-19 rapid antigen test in late September in Europe and intends to file for emergency use authorization (EUA) in the United States. What Happened: The 15-minute test is to be used in point of care settings for both symptomatic and...
-
Abbott Gets FDA Emergency Use Approval For $5 Rapid COVID-19 Test
Wednesday, August 26, 2020 - 9:52pm | 394The United States Food and Drug Administration granted emergency use authorization to a 15-minute COVID-19 test produced by Abbott Laboratories (NYSE: ABT) on Wednesday. What Happened:The BinaxNOW COVID-19 test, priced at $5, is capable of delivering test results without laboratory...
-
Quest Gets FDA Emergency Approval For New Lab Method To Improve Coronavirus Testing Capacity, Speed
Wednesday, July 29, 2020 - 10:07pm | 419Quest Diagnostics Inc (NYSE: DGX) announced Wednesday it had received an emergency use authorization from the Food and Drug Administration for a new laboratory technique that can help signficantly expand and speed up novel coronavirus (COVID-19) testing. What Happened The...